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Abstract – Bioﬁlm formation is an important virulence trait of many bacterial pathogens. It has been
reported in the literature that only two of the reference strains of the swine pathogen Actinobacillus
pleuropneumoniae, representing serotypes 5b and 11, were able to form bioﬁlm in vitro. In this study, we
compared bioﬁlm formation by the serotype 1 reference strain S4074 of A. pleuropneumoniae grown in
ﬁve different culture media. We observed that strain S4074 of A. pleuropneumoniae is able to form
bioﬁlms after growth in one of the culture conditions tested brain heart infusion (BHI medium, supplier
B). Confocal laser scanning microscopy using a ﬂuorescent probe speciﬁc to the poly-N-acetylgluco-
samine (PGA) polysaccharide further conﬁrmed bioﬁlm formation. In accordance, bioﬁlm formation was
susceptible to dispersin B, a PGA hydrolase. Transcriptional proﬁles of A. pleuropneumoniae S4074
following growth in BHI-B, which allowed a robust bioﬁlm formation, and in BHI-A, in which only a
slight bioﬁlm formation was observed, were compared. Genes such as tadC, tadD, genes with homology
to autotransporter adhesins as well as genes pgaABC involved in PGA biosynthesis and genes involved in
zinc transport were up-regulated after growth in BHI-B. Interestingly, bioﬁlm formation was inhibited by
zinc, which was found to be more present in BHI-A (no or slight bioﬁlm) than in BHI-B. We also
observed bioﬁlm formation in reference strains representing serotypes 3, 4, 5a, 12 and 14 as well as in 20
of the 37 fresh ﬁeld isolates tested. Our data indicate that A. pleuropneumoniae has the ability to form
bioﬁlms under appropriate growth conditions and transition from a bioﬁlm-positive to a bioﬁlm-negative
phenotype was reversible.
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1. INTRODUCTION
Actinobacillus pleuropneumoniae,am e m -
ber of the Pasteurellaceae, is an important
swine pathogen responsible for economic
losses in the swine industry. To date, 15 sero-
types of A. pleuropneumoniae have been
described based on capsular antigens [3, 10].
The virulence of the bacteria is mediated by
the coordinated action of several virulence fac-
tors, namely the capsule, lipopolysaccharides
(LPS), Apx toxins and outer membrane pro-
teins involved in iron uptake [4, 11, 14, 18,
19, 28, 29].
It is widely accepted that the majority of
bacteria in virtually all ecosystems (natural, * Corresponding author: mario.jacques@umontreal.ca
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matrix-enclosed bioﬁlms [7]. The matrix
provides bioﬁlm cells with a protected microen-
vironment containing nutrients, secreted
enzymes and DNA. The matrix also contributes
to the increased resistance to antibiotics and
host defenses exhibited by bioﬁlm cells [15].
All members of the Pasteurellaceae are inhab-
itants of mucosal surfaces of mammals and
therefore formation of a bioﬁlm may be crucial
to their persistence in vivo. However, bioﬁlms
have only been investigated in a few species
of the Pasteurellaceae family [16]. In A. pleu-
ropneumoniae, the formation of bioﬁlms on
polystyrene microtiter plate is dependent on
the production of poly-N-acetylglucosamine
(PGA) a linear polymer of N-acetylglucosa-
mine residues in b(1,6) linkage [17, 20]. The
production of PGA is encoded by the genes
pgaABCD [20]. A novel insertion element,
ISApl1, was recently identiﬁed in an A/T rich
region of the pgaC gene of the bioﬁlm-nega-
tive A. pleuropneumoniae strain HB04 [25].
PGA is a substrate for dispersin B (DspB), a
bioﬁlm-releasing glycosyl hydrolase produced
by Aggregatibacter (Actinobacillus) actinomy-
cetemcomitans and A. pleuropneumoniae [20,
22]. It has also been reported that only 2 of
the 15 A. pleuropneumoniae reference strains,
representing serotypes 5b and 11, were able
to form a bioﬁlm in vitro and that the transi-
tion from a bioﬁlm-positive to bioﬁlm-negative
phenotype was irreversible [21]. However, Li
et al. [24] recently observed slight biomass
of bioﬁlm when the A. pleuropneumoniae
serotype 1 reference strain S4074 was grown
in serum-free TSB but not in serum-containing
TSB. In addition, an enhanced bioﬁlm forma-
tion was observed in luxS [24]a n dhns [8]
mutants of A. pleuropneumoniae strain S4074.
The aims of the present study were: (i) to
re-evaluate bioﬁlm formation by A. pleuro-
pneumoniae reference strain S4074 (serotype
1) under different growth conditions using a
standard microtiter plate and crystal violet
staining protocol; (ii) to evaluate the ability
of 16 reference strains and 37 fresh ﬁeld iso-
lates to form bioﬁlm in the growth condition
shown to allow the best bioﬁlm formation
and (iii) to determine the transcriptomic proﬁle
of A. pleuropneumoniae strain S4074 when
grown in that culture condition.
2. MATERIALS AND METHODS
2.1. Bacterial strains and growth conditions
Bacterial strains used in the present study are
listed in Table I. Bacteria were grown on brain heart
infusion agar plates (BHI; Difco Laboratories,
Detroit, MI, USA) supplemented with 15 lg/mL nic-
otinamide adenine dinucleotide (NAD). A colony
was transferred into 5 mL of Luria-Bertani broth
(LB; Difco), tryptic soy broth (TSB; Difco), Mueller
Hinton broth (MH; Difco) or BHI (BHI-A; Difco or
BHI-B; Oxoid Ltd, Basingstoke, Hampshire, UK)
with 5 lg/mL NAD and incubated at 37 Co v e r -
night with agitation. This culture was used for the
bioﬁlm assays.
2.2. Bioﬁlm assay in microtiter plates
The microtiter plate bioﬁlm assay is a static
assay particularly useful for examining early events
in bioﬁlm formation [27] .T h ew e l l so fas t e r i l e
96-well microtiter plate (Costar
 3599, Corning,
NY, USA) were ﬁlled in triplicate with a dilution
(1/100) of an overnight bacterial culture. Following
an incubation of 6 or 24 h at 37 C, the wells were
washed by immersion in water and excess water
was removed by inverting plates onto a paper towel.
The wells were then ﬁlled with 100 lLo fc r y s t a l
violet (0.1%) and the plate was incubated for 2 min
at room temperature. After removal of the crystal
violet solution, the plate was washed and dried
in a 37 C incubator for 30 min and 100 lLo f
ethanol (70%) were added to the wells. Absorbance
was measured at 590 nm using a spectrophotometer
(Powerwave, BioTek Instruments, Winooski,
VT, USA).
2.3. Scanning laser confocal microscopy
The same bioﬁlm assay protocol was used as
described previously. After the 6 or 24 h incubation,
the wells were ﬁlled with 100 lL of Wheat Germ
Agglutinin (WGA)–Oregon Green 488 (Molecular
Probes, Eugene, OR, USA) diluted 1/100 in PBS
and the plate was incubated for 30 min at room tem-
perature in the dark. The plate was then washed with
water and ﬁlled with PBS. The plate was observed
with a confocal microscope (Olympus FV1000
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using 520 nm ﬁlters. The images were processed
using Fluoview software (Olympus).
2.4. Transcriptomic microarray experiments
2.4.1. RNA extractions
For the microarray experiments, BHI-A or BHI-
B broths were inoculated with 500 lLo fa no v e r -
night culture of A. pleuropneumoniae serotype 1
strain S4074 and grown at 37 C in an orbital
shaker until an optical density of 0.6 was reached.
Ice-cold RNA degradation stop solution (95% eth-
anol, 5% buffer-saturated phenol), shown to effec-
tively prevent RNA degradation and therefore
preserve the integrity of the transcriptome [2],
was added to the bacterial culture at a ratio
of 1:10 (vol/vol). The sample was mixed by inver-
sion, incubated on ice for 5 min, and then spun at
50 0 0g for 10 min to pellet the cells. Bacterial
RNA isolation was then carried out using the
QIAGEN RNeasy MiniKit (QIAGEN, Mississauga,
ON, Canada), as prescribed by the manufacturer.
During the extraction, samples were subjected to
Table I. A. pleuropneumoniae strains used in the present study.
Strains Relevant traits Source
Reference strains
S4074 Serotype 1 K.R. Mittal
1
4226 Serotype 2 K.R. Mittal
1
1421 Serotype 3 K.R. Mittal
1
1462 Serotype 4 K.R. Mittal
1
K17 Serotype 5a K.R. Mittal
1
L20 Serotype 5b K.R. Mittal
1
FEMO Serotype 6 K.R. Mittal
1
WF.83 Serotype 7 K.R. Mittal
1
405 Serotype 8 K.R. Mittal
1
13261 Serotype 9 K.R. Mittal
1
13039 Serotype 10 K.R. Mittal
1
56153 Serotype 11 K.R. Mittal
1
832985 Serotype 12 K.R. Mittal
1
N273
4 Serotype 13 M. Gottschalk
1
3906
4 Serotype 14 M. Gottschalk
1
HS143 Serotype 15 M. Gottschalk
1
Field strains
05-7430, 05-7431 Serotype 1 M. Ngeleka
2
111A, 719, 2398, 2521 Serotype 1 D. Slavic
3
05-4817, 05-C996, 06-996 Serotype 5a S. Messier
1
04-37943, 04-3128, 05-508 Serotype 5a M. Ngeleka
2
05-6501, 06-4091 Serotype 5b S. Messier
1
03-14796, 03-22382, 03-22383, 05-4832 Serotype 5b M. Ngeleka
2
366A, 400, 564D, 888 Serotype 5b D. Slavic
3
05-3695, 06-3008, 06-3060, 06-4108 Serotype 7 S. Messier
1
04-37257, 05-14401 Serotype 7 M. Ngeleka
2
881, 986, 1951, 4648 Serotype 7 D. Slavic
3
05-13146, 05-14657, 05-20080, 05-20081, 05-2983 Serotype 15 M. Ngeleka
2
1 Faculte ´d em e ´decine ve ´te ´rinaire, Universite ´ de Montre ´al, St-Hyacinthe, QC, Canada.
2 Prairie Diagnostic Services, University of Saskatchewan, Saskatoon, SK, Canada.
3 Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
4 These strains are NAD-independent and belong to biotype II.
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the manufacturer and then treated with Turbo
DNase (Ambion, Austin, TX, USA) to ensure that
all DNA contaminants were eliminated. The RNA
concentration, quality and integrity were assessed
spectrophotometrically and on gel.
2.4.2. Microarray construction and design
For the construction of AppChip2, 2033 ORFs
from the complete genome sequence of A. pleuro-
pneumoniae serotype 5b strain L20, representing
more than 95% of all ORFs with a length greater
than 160 nt, were ampliﬁed and spotted in duplicate
on the chip. Spotted sheared genomic DNA from
A. pleuropneumoniae L20 and porcine DNA are used
as controls (GEO: GPL6658). Additional informa-
tion concerning chip production is described by
Goure ´e ta l .[ 13].
2.4.3. Microarray hybridizations
cDNA synthesis and microarray hybridizations
were performed as described [6]. Brieﬂy, equal
amounts (15 lg) of test RNA and control RNA were
used to set up a standard reverse transcription reac-
tion using random octamers (BioCorp, Montreal,
QC, Canada), SuperScript II (Invitrogen, Carlsbad,
CA, USA) and aminoallyl-dUTP (Sigma, St. Louis,
MO, USA), and the resulting cDNA was indirectly
labelled using a monofunctional NHS-ester Cy3 or
Cy5 dye (Amersham, Buckinghamshire, UK). The
labelling efﬁciency was assessed spectrophotometri-
cally. Labelled samples were then combined and
added to the AppChip2 for overnight hybridization.
Five hybridizations were performed for the serotype
1 strain S4074 BHI-A versus BHI-B experiments.
All slides were scanned using a Perkin-Elmer Scan-
Array Express scanner.
2.4.4. Microarray analysis and bioinformatics
Microarray data analysis was conducted with the
TM4 Suite of software from the J. Craig Venture
Institute [30] as described by Deslandes et al. [9].
Brieﬂy, raw data was ﬁrst generated using SpotFinder
v.3.1.1. Locally weighted linear regression (lowess)
was then performed in the Microarray Data Analysis
System (MIDAS) in order to normalize the data. The
Signiﬁcance Analysis of Microarray (SAM)
algorithm [33], which is implemented in TIGR
Microarray Expression Viewer (TMEV), was used
to generate a list of differentially expressed genes.
During SAM analysis, a false discovery rate (FDR)
of 0% was estimated for the serotype 1 strain
S4074 BHI-A versus BHI-B experiments.
2.5. Effects of DspB and zinc on bioﬁlm
formation
Bioﬁlms were grown for 6 or 24 h in BHI-B as
described above. The wells were washed with water
a n dt h e nﬁ l l e dw i t h1 0 0lL of PBS containing 0.2,
2.0 or 20 lg/mL of DspB (Kane Biotech Inc, Winni-
peg, MB, Canada) as described by Izano et al. [17].
After incubation at 37 C for 5 min, the wells were
rinsed with water and stained with crystal violet. To
monitor the effect of zinc on bioﬁlm formation, bac-
teria were grown for 6 or 24 h in BHI-B supple-
mented with 50–250 lg/mL of ZnCl2.
2.6. Statistical analysis
The statistical signiﬁcance (p value) of differences
in bioﬁlm phenotypes (mean optical density values)
was determined by a paired, one-tailed t-test using
GraphPad Prism version 4.0 (GraphPad Software,
San Diego, CA, USA).
3. RESULTS
3.1. Bioﬁlm formation and growth conditions
The ability of the A. pleuropneumoniae sero-
type 1 reference strain S4074 to form bioﬁlms
was evaluated using different growth media
(Fig. 1). No bioﬁlm was present in the wells
containing bacterial cells grown in LB broth
while only a slight bioﬁlm was observed in
wells containing cells grown in TSB, MH or
BHI-A broths after 24 h of incubation. How-
ever a pronounced bioﬁlm (p < 0.01) was
formed when strain S4074 was grown in
BHI-B broth. This was not due to an increased
growth in BHI-B compared to BHI-A as similar
growth curves were observed in both media.
We then evaluated bioﬁlm formation by all
the reference strains of A. pleuropneumoniae
after growth for 6 or 24 h in BHI-B. Similarly
to what was observed with the serotype 1, we
found that growth in BHI-B, but not BHI-A,
allows bioﬁlm formation in reference strains
representing serotypes 4, 5a and 14. In addition
Vet. Res. (2010) 41:03 J. Labrie et al.
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otypes 5b and 11, we also observed bioﬁlms for
serotype 3 and 12 reference strains. Moreover,
bioﬁlm formation (OD590nm >0 . 1 ) w a s
observed in 20 (54%) of the 37 fresh ﬁeld iso-
lates of serotypes 1, 5, 7 and 15 that were tested
(Fig. 2). In general, serotypes 5a, 5b and 7 ﬁeld
isolates tend to form more bioﬁlms (mean OD
of 1.15, 1.47 and 1.47 after 24 h) than isolates
from serotypes 1 and 15 (mean OD of 0.36 and
0.80 after 24 h).
When A. pleuropneumoniae strain S4074
g r o w ni nB H I - A( n oo rs l i g h tb i o ﬁ l m )w a s
transferred to BHI-B we observed the formation
of a pronounced bioﬁlm (p <0 . 0 5 ) . W h e n
these cells were then transferred back to BHI-
A, the phenotype returned to a slight bioﬁlm
(p < 0.05). This was also observed with ﬁeld
isolates representing different serotypes (data
not shown).
3.2. Scanning laser confocal microscopy
We observed that for many reference strains,
including strain S4074, and ﬁeld isolates, pro-
nounced bioﬁlms were present after a short
incubation period of only 6 h (Fig. 2). The
bioﬁlm was visualized by confocal laser scan-
ning microscopy using a ﬂuorescent probe
(WGA-Oregon Green) speciﬁc to the PGA
matrix polysaccharide (Fig. 3). It is evident
from these micrographs that A. pleuropneumo-
niae strain S4074 does not form bioﬁlm when
grown in BHI-A while a thick PGA matrix is
formed by A. pleuropneumoniae serotype 5b
strain L20 grown in the same condition. How-
ever, both strains showed a pronounced bioﬁlm
when grown in BHI-B. In the case of strain
S4074, the bioﬁlm is even more important after
6 h than 24 h of incubation (Fig. 3). Because
scanning laser confocal microscopy allows opti-
cal sectioning of the bioﬁlm either in the hori-
zontal or the vertical dimension it is possible
to evaluate the thickness of the bioﬁlm. We
evaluated the thickness of A. pleuropneumoniae
strain S4074 bioﬁlm to be of   25 lma f t e r
growth in BHI-B for 6 h (Fig. 3C) and even
greater (  65 lm) for A. pleuropneumoniae
strain L20.
3.3. Transcriptomic proﬁling under different
growth conditions
To assess the transcriptional response of
A. pleuropneumoniae S4074 after growth in
BHI-B compared to BHI-A, transcript proﬁling
experiments using DNA microarrays were per-
formed. Overall, 232 genes were signiﬁcantly
differentially expressed during growth in BHI-
B; 152 being up-regulated and 80 being
down-regulated (Tab. II). The genes that
showed the highest level of up-regulation after
growth in BHI-B belonged to the ‘‘amino acid
biosynthesis’’, ‘‘energy metabolism’’, ‘‘trans-
port and binding proteins’’, ‘‘cell envelope’’
and ‘‘hypothetical/unknown/unclassiﬁed’’ func-
tional classes (Fig. 4). Genes such as tadC and
tadD (tight adherence proteins C and D), genes
with homology to autotransporter adhesins
(APL_0443 and APL_0104) as well as genes
pgaABC involved in PGA biosynthesis were
up-regulated after growth in BHI-B. A cluster
of genes involved in dipeptide transport
(dppABCDF) and genes involved in the
synthesis of an urease (ureAEFG)w e r ea l s o
up-regulated. Down-regulated genes after
growth in BHI-B mostly belonged to the
‘‘transport and binding proteins’’, ‘‘cell enve-
lope’’, ‘‘protein synthesis’’ and ‘‘hypothetical/
Figure 1. Bioﬁlm formation by A. pleuropneu-
moniae serotype 1 reference strain S4074 grown
in different culture media using the crystal violet
staining protocol described in Materials and
methods. LB: Luria-Bertani; TSB: tryptic soy
broth; M-H: Mueller Hinton; BHI: brain heart
infusion.
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notably, cys genes involved in sulphate trans-
port systems were down-regulated, as well as
a gene (APL_1096) sharing 59% identity with
t h eD s p Bg e n eo fA. actinomycetemcomitans.
3.4. Effect of DspB on bioﬁlm formation
Enzymatic treatment with DspB of bioﬁlms
of A. pleuropneumoniae strains S4074 and
L20 grown for 6 or 24 h almost completely dis-
persed them (p < 0.05) conﬁrming the presence
of PGA in the bioﬁlm matrix.
3.5. Effect of zinc on bioﬁlm formation
Chemical analysis showed differences in
some divalent cations concentration between
BHI-A (Fe < 0.10 ppm, Zn 2.03 ppm) and
BHI-B (Fe 0.10 ppm, Zn 1.75 ppm) while no
differences were observed for others (Ca, Cu,
Mg, Mn). We therefore hypothesized that the
difference in bioﬁlm formation observed after
growth in BHI-B compared to BHI-A might
be due to cations concentration. Since the
concentration of zinc was found to be higher
in BHI-A (no or slight bioﬁlm) we tested a
Figure 2. Thirty-seven independent fresh ﬁeld isolates of A. pleuropneumoniae (representing serotypes 1,
5, 7 and 15) were tested for their ability to form bioﬁlms when grown for 6 h (A) and 24 h (B) in BHI-B
using the microtiter plate assay.
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ﬁlm formation. The addition of ZnCl2 to BHI-
B inhibited, in a dose-dependent manner, the
formation of bioﬁlms by A. pleuropneumoniae
strains S4074 and L20 (Fig. 5). A complete
inhibition (p < 0.01) was observed when
100 lg/mL of ZnCl2 was added to BHI-B, a
concentration which did not affect growth
after 24 h (data not shown). A similar inhibition
was also observed with the addition of ZnSO4,
ZnO, and Zn3(PO4)2 but not with MgCl2 or
CaCl2 thus conﬁrming that the inhibition was
due to the addition of zinc. Bioﬁlm formation
in A. actinomycetemcomitans was also inhibited
Figure 3. Confocal scanning laser microscopic images of A. pleuropneumoniae serotype 1 strain S4074 (A
and C) and serotype 5b strain L20 (B) bioﬁlms stained with WGA-Oregon Green 488. (C) Stack of sections
through the X–Z plane of a bioﬁlm formed after 6 h in BHI-B. Bars = 50 lm.
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compared to growth in BHI-A.
Locus tag Gene Description Fold change
Amino acid biosynthesis
APL_0728 ilvH Acetolactate synthase small subunit 5.707
APL_0662 aspC Putative aspartate aminotransferase 5.324
APL_0427 gdhA NADP-speciﬁc glutamate dehydrogenase 4.943
APL_0727 ilvI Acetolactate synthase large subunit 4.204
APL_0099 ilvG Acetolactate synthase isozyme II large subunit (AHAS-II) 3.915
APL_1499 thrC Threonine synthase 3.198
APL_0097 ilvD Dihydroxy-acid dehydratase 3.142
APL_0393 leuA 2-isopropylmalate synthase 3.000
APL_0098 ilvM Acetolactate synthase isozyme II small subunit (AHAS-II) 2.934
APL_2027 hisF Imidazole glycerol phosphate synthase subunit hisF 2.833
APL_0702 serC Phosphoserine aminotransferase 2.788
APL_0432 leuB 3-isopropylmalate dehydrogenase 2.643
APL_0899 dapA Dihydrodipicolinate synthase 2.401
APL_0211 glyA Glycine/serine hydroxymethyltransferase 2.398
APL_0133 cysB HTH-type transcriptional regulator CysB 2.340
APL_1853 ilvC Ketol-acid reductoisomerase 2.313
APL_0072 ilvE Branched-chain-amino-acid aminotransferase 2.001
APL_0859 trpCF Tryptophan biosynthesis protein trpCF 1.883
APL_2025 hisH Imidazole glycerol phosphate synthase subunit hisH 1.777
APL_2026 hisA Phosphoribosylformimino-5-aminoimidazole carboxamide
ribotide isomerase
1.739
APL_1198 APL_1198 Putative NAD(P)H nitroreductase 1.708
APL_0139 leuC 3-isopropylmalate dehydratase large subunit 2 1.605
APL_1230 serB Phosphoserine phosphatase 1.438
APL_0620 aroG Phospho-2-dehydro-3-deoxyheptonate aldolase 1.428
APL_1873 dapE Succinyl-diaminopimelate desuccinylase 1.380
Biosynthesis of cofactors, prosthetic groups, and carriers
APL_0207 Dxs 1-deoxy-D-xylulose-5-phosphate synthase (DXPS)  1.555
APL_1461 menA 1,4-dihydroxy-2-naphthoateoctaprenyltransferase  1.631
APL_0382 ribD Riboﬂavin biosynthesis protein  1.726
APL_1408 gshA Glutathione biosynthesis bifunctional protein GshAB  1.789
Cell envelope
APL_1494 ftpA Fine tangled pili major subunit 5.705
APL_1921 pgaA Bioﬁlm PGA synthesis protein PgaA precursor 5.308
APL_0460 plpD Lipoprotein Plp4 3.801
APL_1923 pgaC Bioﬁlm PGA synthesis N-glycosyltransferase PgaC 3.591
APL_1922 pgaB Bioﬁlm PGA synthesis lipoprotein PgaB precursor 3.093
APL_0006 ompP2A Outer membrane protein P2 2.515
APL_0550 tadC Tight adherence protein C 1.985
APL_0442 sanA SanA protein 1.776
APL_0549 tadD Tight adherence protein D 1.749
APL_0332 hlpB Lipoprotein HlpB 1.627
APL_1364 gmhA Putative phosphoheptose isomerase 1.386
APL_0873 rlpB Putative rare lipoprotein B  1.391
Continued on next page
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Locus tag Gene Description Fold change
APL_1028 APL_1028 Possible lipooligosaccharide N-acetylglucosamine
glycosyltransferase
 1.445
APL_0747 mepA Penicillin-insensitive murein endopeptidase precursor  1.446
APL_0436 mreC Rod shape-determining protein MreC  1.585
APL_1086 ompW Outer membrane protein W precursor  1.606
APL_1029 APL_1029 Hypothetical protein  1.650
APL_1424 oxaA Inner membrane protein OxaA  1.772
APL_0933 ompP1 Putative outer membrane protein precursor  2.808
Cellular processes
APL_1489 Tpx Putative thiol peroxidase 2.252
APL_0988 hktE Catalase  1.461
APL_0669 APL_0669 Putative iron dependent peroxidase  1.483
APL_1442 apxID RTX-I toxin secretion component  1.506
APL_1346 ftsY Cell division protein FtsY-like protein  1.530
Central intermediary metabolism
APL_1615 Gst Putative glutathione S-transferase 3.269
APL_1614 ureE Urease accessory protein UreE 2.601
APL_1613 ureF Urease accessory protein UreF 2.478
APL_1612 ureG Urease accessory protein UreG 2.165
APL_1618 ureA Urease gamma subunit UreA 1.653
DNA metabolism
APL_1931 tagI 3-methyladenine-DNA glycosidase  1.500
APL_1474 dnaG DNA primase  1.551
APL_1282 dnaQ DNA polymerase III subunit  1.579
APL_1255 parE DNA topoisomerase IV subunit  1.630
APL_1505 holC DNA polymerase III subunit  1.663
Energy metabolism
APL_1197 APL_1197 3-hydroxyacid dehydrogenase 3.100
APL_0841 pntB NAD(P) transhydrogenase subunit beta 2.726
APL_1908 xylA Xylose isomerase 2.243
APL_0894 fdxH Formate dehydrogenase, iron-sulfur subunit 2.161
APL_1425 napC Cytochrome c-type protein NapC 2.159
APL_1799 torC Pentahemic c-type cytochrome 2.156
APL_0892 fdxG Formate dehydrogenase, nitrate-inducible, major subunit 2.116
APL_1798 torA Trimethylamine-N-oxide reductase precursor 1.977
APL_0381 glpC Anaerobic glycerol-3-phosphate dehydrogenase subunit C 1.919
APL_0842 pntA NAD(P) transhydrogenase subunit alpha 1.903
APL_0895 fdnI Formate dehydrogenase, cytochrome b556 subunit 1.816
APL_1208 adhC Putative alcohol dehydrogenase class 3 1.801
APL_0971 APL_0971 Putative acyl CoA thioester hydrolase 1.796
APL_0652 manB Phosphomannomutase 1.677
APL_0483 APL_0483 Predicted nitroreductase 1.668
APL_0142 glxK Glycerate kinase 1.564
APL_0452 sucC Succinyl-CoA synthetase beta chain 1.515
APL_0461 APL_0461 Predicted hydrolases of the HAD superfamily 1.456
Continued on next page
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Locus tag Gene Description Fold change
APL_0687 Dld D-lactate dehydrogenase 1.439
APL_1510 gpsA Glycerol-3-phosphate dehydrogenase (NAD(P)+) 1.414
APL_1427 napH Ferredoxin-type protein NapH-like protein 1.360
APL_0789 APL_0789 Dioxygenase 1.253
APL_0983 tktA Transketolase 2 1.233
APL_1036 pﬂB Formate acetyltransferase  1.653
APL_1498 mgsA Methylglyoxal synthase  1.790
APL_1840 ubiC 4-hydroxybenzoate synthetase (chorismate lyase)  1.952
APL_0857 sdaA L-serine dehydratase  3.016
Fatty acid and phospholipid metabolism
APL_1407 Psd Phosphatidylserine decarboxylase  1.419
APL_1384 fabH 3-oxoacyl-[acyl-carrier-protein] synthase 3  1.826
APL_1385 plsX Fatty acid/phospholipid synthesis protein PlsX  2.706
Mobile and extrachromosomal element functions
APL_1056 APL_1056 Transposase 1.560
APL_0985 APL_0985 Transposase 1.271
Protein fate
APL_0871 pepE Peptidase E 2.551
APL_1101 pepA Putative cytosol aminopeptidase 1.913
APL_0254 pepD Aminoacyl-histidine dipeptidase 1.903
APL_1883 ptrA Protease 3 precursor 1.680
APL_0928 hscB Co-chaperone protein HscB-like protein 1.377
APL_1068 secF Protein-export membrane protein SecF  1.496
APL_0321 dsbB Disulﬁde bond formation protein B  1.557
APL_1035 pﬂA Pyruvate formate-lyase 1-activating enzyme  1.774
Protein synthesis
APL_1821 rpmE 50S ribosomal protein L31 2.211
APL_0484 rimK Ribosomal protein S6 modiﬁcation protein 1.533
APL_1781 rpsM 30S ribosomal protein S13  1.401
APL_0205 APL_0205 Predicted rRNA methyltransferase  1.538
APL_0399 ksgA Dimethyladenosine transferase  1.578
APL_0679 glnS Glutaminyl-tRNA synthetase  1.584
APL_0641 truB tRNA pseudouridine synthase B  1.742
APL_1383 trmB tRNA (guanine-N(7)-)-methyltransferase  1.756
APL_0574 APL_0574 tRNA-speciﬁc adenosine deaminase  1.778
APL_0723 Tgt Queuine tRNA-ribosyltransferase  1.937
Purines, pyrimidines, nucleosides, and nucleotides
APL_0958 purH Bifunctional purine biosynthesis protein PurH 1.856
APL_0593 guaB Inosine-50-monophosphate dehydrogenase 1.485
APL_1343 Cdd Cytidine deaminase 1.278
APL_1014 deoD Purine nucleoside phosphorylase DeoD-like protein  1.430
APL_0351 Ndk Nucleoside diphosphate kinase  1.531
APL_1839 Udp Uridine phosphorylase  1.617
APL_1075 purA Adenylosuccinate synthetase  1.762
Continued on next page
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Locus tag Gene Description Fold change
Regulatory functions
APL_0059 narP Nitrate/nitrite response regulator protein 2.552
APL_0823 glpR Glycerol-3-phosphate regulon repressor 1.908
APL_1295 argR Arginine repressor 1.896
APL_0126 APL_0126 HIT-like protein 1.580
APL_0395 rseA Putative sigma-E factor negative regulatory protein 1.524
APL_1668 rbsR Ribose operon repressor 1.302
APL_1270 sprT Putative SprT-like protein  1.483
APL_1233 malT HTH-type transcriptional regulator MalT  1.484
APL_1540 tldD TldD-like protein  1.578
Transcription
APL_0560 rhlB ATP-dependent RNA helicase RhlB 1.409
APL_0423 rnhA Ribonuclease HI 1.345
APL_0201 nusB Transcription antitermination protein NusB  1.457
Transport and binding proteins
APL_0967 gltS Sodium/glutamate symport carrier protein 4.155
APL_0377 glpT Glycerol-3-phosphate transporter 3.247
APL_0064 dppA Periplasmic dipeptide transport protein 3.168
APL_0869 abgB Aminobenzoyl-glutamate utilization-like protein 3.004
APL_1857 merP Copper chaperone MerP 2.911
APL_0068 dppF Dipeptide transport ATP-binding protein DppF 2.860
APL_1665 gntP_1 Gluconate permease 2.723
APL_0066 dppC Dipeptide transport system permease protein DppC 2.640
APL_1440 znuA High-afﬁnity zinc uptake system protein ZnuA precursor 2.600
APL_0065 dppB Dipeptide transport system permease protein DppB 2.229
APL_0067 dppD Dipeptide transport ATP-binding protein DppD 2.036
APL_1448 afuC Ferric ABC transporter ATP-binding protein 1.855
APL_1319 ptsB PTS system sucrose-speciﬁc EIIBC component 1.744
APL_1320 thiQ Thiamine transport ATP-binding protein ThiQ 1.569
APL_1622 cbiM Predicted ABC transport permease protein CbiM 1.433
APL_1620 cbiO Predicted ABC transport ATP-binding protein CbiO 1.417
APL_1173 pnuC Nicotinamide mononucleotide transporter 1.408
APL_0749 APL_0749 Potassium efﬂux system KefA  1.436
APL_1212 tehA Tellurite resistance protein TehA  1.543
APL_0716 APL_0716 Iron(III) ABC transporter, permease protein  1.547
APL_1253 APL_1253 Putative sodium/sulphate transporter  1.598
APL_1846 cysT Sulfate transport system permease protein cysT  1.684
APL_0191 APL_0191 Predicted Na+-dependent transporter of the SNF family  1.751
APL_1083 arcD Putative arginine/ornithine antiporter  1.786
APL_2016 fhuA Ferrichrome-iron receptor FhuA  2.031
APL_1847 cysW Sulfate transport system permease protein cysW  2.195
APL_1844 cysN Sulphate adenylate transferase subunit 1  2.375
APL_1848 cysA Sulfate/thiosulfate import ATP-binding protein cysA  2.401
APL_1843 cysJ Sulﬁte reductase [NADPH] ﬂavoprotein
alpha-component
 2.757
APL_1127 APL_1127 Predicted Na+/alanine symporter  3.402
Continued on next page
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Hypothetical/unknown/unclassiﬁed
APL_1100 APL_1100 Hypothetical protein 3.395
APL_0920 APL_0920 Hypothetical protein 2.835
APL_1882 APL_1882 Hypothetical protein 2.776
APL_1856 APL_1856 Hypothetical protein 2.775
APL_1855 APL_1855 Hypothetical protein 2.763
APL_0443 APL_0443 Autotransporter adhesin 2.762
APL_1252 APL_1252 Hypothetical protein 2.739
APL_0134 APL_0134 Hypothetical protein 2.681
APL_0836 APL_0836 Putative transcriptional regulator 2.661
APL_1588 APL_1588 Predicted TRAP transporter solute receptor 2.464
APL_1491 APL_1491 Hypothetical protein 2.282
APL_0104 APL_0104 Autotransporter adhesin 2.231
APL_1069 ftnA Ferritin-like protein 1 2.194
APL_1059 APL_1059 Hypothetical transposase-like protein 2.172
APL_1690 APL_1690 Inner membrane protein 2.168
APL_0245 APL_0245 Transferrin binding protein-like solute binding protein 2.097
APL_1191 namA NADPH dehydrogenase 2.078
APL_1948 APL_1948 Hypothetical protein 2.061
APL_0870 APL_0870 Putative C4-dicarboxylate transporter 2.034
APL_0643 APL_0643 Hypothetical protein 2.029
APL_1743 APL_1743 Ser/Thr protein phosphatase family protein 1.999
APL_0426 APL_0426 Hypothetical protein 1.994
APL_1791 APL_1791 Putative periplasmic iron/siderophore binding protein 1.944
APL_0970 APL_0970 Hypothetical protein 1.908
APL_1070 ftnB Ferritin-like protein 2 1.907
APL_1894 APL_1894 Hypothetical protein 1.907
APL_1374 APL_1374 Hypothetical protein 1.803
APL_1206 APL_1206 Plasmid stability-like protein 1.794
APL_1881 APL_1881 Hypothetical protein 1.792
APL_0038 APL_0038 Hypothetical protein 1.730
APL_1355 APL_1355 Hypothetical protein 1.716
APL_0471 APL_0471 Hypothetical protein 1.707
APL_1438 APL_1438 Hypothetical protein 1.689
APL_1437 APL_1437 Hypothetical protein 1.643
APL_1423 APL_1423 Hypothetical protein 1.612
APL_0125 APL_0125 Hypothetical protein 1.608
APL_0096 APL_0096 Zinc transporter family protein ZIP 1.592
APL_0220 APL_0220 Putative lipoprotein 1.583
APL_1934 APL_1934 Hypothetical protein 1.570
APL_1574 APL_1574 Hypothetical protein 1.543
APL_0036 APL_0036 Hypothetical protein 1.533
APL_0222 APL_0222 Putative lipoprotein 1.518
APL_1088 APL_1088 Hypothetical protein 1.512
APL_1207 APL_1207 Hypothetical protein 1.510
APL_0463 APL_0463 Predicted sortase and related acyltransferases 1.448
APL_1859 APL_1859 Probable NADH-dependent butanol dehydrogenase 1 1.448
APL_1828 APL_1828 PilT protein-like protein 1.447
Continued on next page
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potentially involved in zinc transport (znuA
and APL_0096) were up-regulated after growth
in BHI-B (Tab. II).
4. DISCUSSION
Bioﬁlm formation is an important virulence
trait of many bacterial pathogens including
A. pleuropneumoniae. It has been previously
reported that only 2 of the 15 A. pleuropneumo-
niae reference strains, representing serotypes 5b
and 11, were able to form a bioﬁlm in vitro
[21]. We observed however an increased stick-
iness of colonies when strain A. pleuropneumo-
niae S4074 was grown on plates made of BHI
from one of two different suppliers. In addition,
Li et al. [24] recently observed slight biomass
of bioﬁlm when the A. pleuropneumoniae sero-
type 1 reference strain S4074 was grown in
serum-free TSB and that an enhanced bioﬁlm
formation was observed in luxS [24]a n dhns
[8] mutants of A. pleuropneumoniae S4074.
These observations brought us to re-evaluate
bioﬁlm formation by strain A. pleuropneumo-
niae S4074 under different growth conditions
using a standard microtiter plate and crystal vio-
let staining protocol. Our data indicate that
strain S4074 has the ability to form a pro-
nounced bioﬁlm when grown in the appropriate
conditions, and that the bioﬁlm was sensitive to
DspB treatment and can be inhibited by zinc.
Transition from a bioﬁlm-positive to a bio-
ﬁlm-negative phenotype is not irreversible in
contrast to what was reported by Kaplan and
Mulks [21] under different conditions.
Transcript proﬁling experiments using DNA
microarrays indicated that overall, 232 genes
were signiﬁcantly differentially expressed dur-
ing growth in BHI-B. Genes such as tadC,
tadD, genes with homology to autotransporter
adhesins as well as genes pgaABC involved
in PGA biosynthesis were up-regulated after
Table II. Continued.
Locus tag Gene Description Fold change
APL_0433 msrB Methionine sulfoxide reductase B 1.415
APL_1189 APL_1189 Hypothetical protein 1.393
APL_0090 APL_0090 Hypothetical protein 1.360
APL_1709 APL_1709 Hypothetical protein  1.307
APL_0357 APL_0357 Hypothetical protein  1.328
APL_1380 APL_1380 Hypothetical protein  1.394
APL_1729 APL_1729 Hypothetical protein  1.401
APL_1062 APL_1062 Hypothetical protein  1.468
APL_0179 APL_0179 Hypothetical protein  1.481
APL_0940 APL_0940 Hypothetical protein  1.482
APL_1273 APL_1273 Putative ﬁmbrial biogenesis and twitching motility protein
PilF-like protein
 1.488
APL_1131 APL_1131 Hypothetical protein  1.540
APL_0583 APL_0583 Hypothetical protein  1.585
APL_1096 APL_1096 Hypothetical protein (59% ID dispersine B)  1.594
APL_0936 APL_0936 Hypothetical protein  1.616
APL_1115 APL_1115 Hypothetical protein  1.639
APL_0811 APL_0811 Hypothetical protein  1.682
APL_1898 ap2029 Hypothetical protein  1.798
APL_1654 gidB Methyltransferase GidB  1.816
APL_0340 APL_0340 Hypothetical protein  1.893
APL_1381 APL_1381 Hypothetical protein  1.926
APL_0053 typA GTP-binding protein  2.043
APL_1681 APL_1681 Hypothetical protein  2.233
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that these genes might be important for the for-
mation of the bioﬁlm itself, it is also interesting
to note that many of the same genes (tadB,
rcpA, gene APL_0443 with high homology to
the Hsf autotransporter adhesin of Haemophilus
inﬂuenzae as well as genes pgaBC involved in
bioﬁlm biosynthesis) were up-regulated, when
the transcriptomic proﬁle of A. pleuropneumo-
niae was determined after contact with porcine
lung epithelial cells [1], thus emphasizing the
possible importance of bioﬁlm formation for
the establishment of the infection.
Initial steps in bioﬁlm development require
the transcription, early on, of genes involved
in reversible attachment and motility, before a
subsequent switch towards the transcription of
genes involved in the irreversible attachment
of bacteria [35]. This second irreversible attach-
ment might require the synthesis of adhesive
organelles, such as the curli ﬁbers (csg genes).
Interestingly, gene APL_0220 is a putative lipo-
protein of the CsgG family, responsible for
the transport and assembly of curli ﬁbers. The
up-regulation of other genes possibly involved
in adhesion processes (tadC, tadD, Hsf homo-
log APL_0443) might indicate that bacterial
cells were entering or in the middle of this irre-
versible attachment phase. In A. actinomyce-
temcomitans, the Tad locus is essential for
bioﬁlm formation [32]. The fact that the tran-
scription of a zinc-speciﬁc transporter (znuA)
was increased, combined with the decrease in
transcription of an hypothetical Zn-dependant
Figure 4. Functional classiﬁcation of the differentially expressed genes during growth of A. pleuropneu-
moniae S4074 in BHI-B according to TIGRFAM. AAB: amino acids biosynthesis; BCPC: biosynthesis of
cofactors, prosthetic groups and carriers; CE: cell envelope; CP: cellular processes; CIM: central
intermediary metabolism; DNA: DNA metabolism; EM: energy metabolism; FAPM: fatty acid and
phospholipid metabolism; HUU: hypothetical proteins/unclassiﬁed/unknown; MEEF: mobile and extra-
chromosomal element functions; PF: protein fate; PS: protein synthesis; PPNN: purines, pyrimidines,
nucleosides and nucleotides; RF: regulatory functions; TR: transcription and TBP: transport and binding
proteins.
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of this metal in BHI-B lead us to believe that
Zn restriction might be a signal leading to
increase bioﬁlm formation.
It is tempting to speculate that growth in
BHI-B affected the expression of regulators
w h i c hi nt u r na f f e c t e dP G Ae x p r e s s i o na n db i o -
ﬁlm formation. Indeed, it has been recently
shown that an enhanced bioﬁlm formation
was observed in a hns mutant of A. pleuropneu-
moniae strain S4074 [8] and that over-expres-
sion of RpoE in a rseA mutant is sufﬁcient to
alleviate repression of bioﬁlm formation by
H-NS
1. However, other genes have been shown
to affect bioﬁlm formation in A. pleuropneumo-
niae. An enhanced bioﬁlm formation was
observed in a quorum sensing (luxS) mutant
[24] while a mutant in the ArcAB two-compo-
nent system facilitating metabolic adaptation to
anaerobicity (arcA)[ 5] and an autotransporter
serine protease (AasP) mutant were deﬁcient
in bioﬁlm formation [31]. It is interesting to
note that many genes involved in branched-
chain amino acid biosynthesis (ilv genes) were
up-regulated after growth in BHI-B. Limitation
of branched-chain amino acids was shown to be
a cue for expression of a subset of in vivo
induced genes in A. pleuropneumoniae,i n c l u d -
ing not only genes involved in the biosynthesis
of branched-chain amino acids, but also other
genes that are induced during infection of the
natural host [34].
Our data indicate that many strains of
A. pleuropneumoniae have the ability to form
bioﬁlms under appropriate growth conditions.
This is an important observation considering
that A. pleuropneumoniae bioﬁlm cells exhibit
increased resistance to antibiotics compared to
planktonic cells [17] and may also exhibit
increased resistance to biocides [12]. Bioﬁlms
are often associated with chronic infections
but the fact that A. pleuropneumoniae can form
an important bioﬁlm after only 6 h of incuba-
tion suggests that bioﬁlm formation might also
play a role in acute infections.
We have undertaken the screen of a large
library of mini-Tn10 isogenic mutants of
A. pleuropneumoniae S4074 in order to iden-
tify other genes that are involved in bioﬁlm
1 Bosse J.T., Sinha S., O’Dwyer C.A., Rycroft
A.N., Kroll J.S., Langford P.R., H-NS is a speciﬁc
regulator of bioﬁlm formation in Actinobacillus
pleuropneumoniae, Proceedings of the International
Pasteurellaceae Society meeting, Sorrento, Italy,
2008, p. 110.
Figure 5. Effect of the addition of ZnCl2 on bioﬁlm formation by A. pleuropneumoniae serotype 1 strain
S4074 (App1) and serotype 5b strain L20 (App5b) grown for 6 h.
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standing of bioﬁlm formation in A. pleuropneu-
moniae might lead to the development of
molecules or strategies to interfere with bioﬁlm
formation and prevent infection in pigs. In that
respect, we made an important, and unexpected,
observation that zinc could completely inhibit
bioﬁlm formation in A. pleuropneumoniae and
A. actinomycetemcomitans, which also synthe-
sizes PGA [20]. We do not know at this time
how zinc interferes with PGA biosynthesis and
bioﬁlm formation but some glycosyltransferases
have been shown to be inhibited by zinc [23].
Hypozincemia which occurs during infection
and inﬂammation [26] might therefore favour
bioﬁlm formation by A. pleuropneumoniae.
Knowing that PGA functions as a bioﬁlm
matrix polysaccharide in phylogenetically
diverse bacterial species such as Staphylococcus
aureus, S. epidermidis,a n dEscherichia coli
[20], it would be worth investigating whether
zinc can also interfere with PGA biosynthesis
in these other bacterial pathogens.
Acknowledgements. This work was supported by
a discovery grant from the Natural Sciences and
Engineering Research Council of Canada
(DGPIN0003428) to M. Jacques. The authors would
also like to acknowledge the contribution of Patrick
Vincent for confocal microscopy.
REFERENCES
[1] Auger E., Deslandes V., Ramjeet M., Contreras I.,
Nash J.H., Harel J., et al., Host pathogen interactions
of Actinobacillus pleuropneumoniae with porcine lung
and tracheal epithelial cells, Infect. Immun. (2009)
77:1426–1441.
[2] Bernstein J.A., Khodursky A.B., Lin P.H.,
Lin-Chao S., Cohen S.N., Global analysis of mRNA
decay and abundance in Escherichia coli at single-
gene resolution using two-color ﬂuorescent DNA
microarrays, Proc. Natl. Acad. Sci. USA (2002)
99:9697–9702.
[3] Blackall P.J., Klaasen H.L., van den Bosch H.,
Kuhnert P., Frey J., Proposal of a new serovar of
Actinobacillus pleuropneumoniae: serovar 15, Vet.
Microbiol. (2002) 84:47–52.
[4] Bosse J.T., Janson H., Sheehan B.J., Beddek A.J.,
Rycroft A.N., Kroll J.S., Langford P.R., Actinobacillus
pleuropneumoniae: pathobiology and pathogenesis of
infection, Microbes Infect. (2002) 4:225–235.
[5] Buettner F.F., Maas A., Gerlach G.-F., An Acti-
nobacillus pleuropneumoniae arcA deletion mutant is
attenuated and deﬁcient in bioﬁlm formation, Vet.
Microbiol. (2008) 127:106–115.
[6] Carrillo C.D., Taboada E., Nash J.H., Lanthier P.,
Kelly J., Lau P.C., et al., Genome-wide expression
analyses of Campylobacter jejuni NCTC11168 reveals
coordinate regulation of motility and virulence by ﬂhA,
J. Biol. Chem. (2004) 279:20327–20338.
[7] Costerton J.W., Springer series on bioﬁlms: the
bioﬁlm primer, Springer-Verlag, Berlin Heidelberg,
2007.
[8] Dalai B., Zhou R., Wan Y., Kang M., Li L., Li T.,
et al., Histone-like protein H-NS regulates bioﬁlm
formation and virulence of Actinobacillus pleuropneu-
moniae, Microb. Pathog. (2009) 46:128–134.
[9] Deslandes V., Nash J.H., Harel J., Coulton J.W.,
Jacques M., Transcriptional proﬁling of Actinobacillus
pleuropneumoniae under iron-restricted conditions,
BMC Genomics (2007) 8:72.
[10] Dubreuil J.D., Jacques M., Mittal K.R.,
Gottschalk M., Actinobacillus pleuropneumoniae sur-
face polysaccharides: their role in diagnosis and immu-
nogenicity, Anim. Health Res. Rev. (2000) 1:73–93.
[11] Frey J., RTX toxin-determined virulence in
Pasteurellaceae, in: Kuhnert P., Christensen H.
(Eds.), Pasteurellaceae – biology, genomics and
molecular aspects, Caister Academic Press, Norfolk,
UK, 2008, pp. 133–144.
[12] Ganeshnarayan K., Shah S.M., Libera M.R.,
Santostefano A., Kaplan J.B., Poly-N-acetylglucosa-
mine matrix polysaccharide impedes ﬂuid convection
and transport of the cationic surfactant cetylpyridinium
chloride through bacterial bioﬁlms, Appl. Environ.
Microbiol. (2009) 75:1308–1314.
[13] Goure ´ J., Findlay W.A., Deslandes V., Bouevitch
A., Foote S.J., MacInnes J.I., et al., Microarray-based
comparative genomic proﬁling of reference strains and
selected Canadian ﬁeld isolates of Actinobacillus
pleuropneumoniae, BMC Genomics (2009) 10:88.
[14] Haesebrouck F., Chiers K., Van Overbeke I.,
Ducatelle R., Actinobacillus pleuropneumoniae infec-
tions in pigs: the role of virulence factors in
pathogenesis and protection, Vet. Microbiol. (1997)
58:239–249.
[15] Hall-Stoodley L., Costerton J.W., Stoodley P.,
Bacterial bioﬁlms: from the natural environment to
infectious diseases, Nat. Rev. Microbiol. (2004) 2:
95–108.
Vet. Res. (2010) 41:03 J. Labrie et al.
Page 16 of 17 (page number not for citation purpose)[16] Inzana T.J., Swords W.E., Sandal I., Siddaram-
appa S., Lipopolysaccharides, bioﬁlms and quorum
sensing in Pasteurellaceae, in: Kuhnert P., Christensen
H. (Eds.), Pasteurellaceae – biology, genomics and
molecular aspects, Caister Academic Press, Norfolk,
UK, 2008, pp. 177–195.
[17] Izano E.A., Sadovskaya I., Vinogradov E.,
Mulks M.H., Velliyagounder K., Ragunath C., et al.,
Poly-N-acetylglucosamine mediates bioﬁlm formation
and antibiotic resistance in Actinobacillus pleuropneu-
moniae, Microb. Pathog. (2007) 43:1–9.
[18] Jacques M., Role of lipo-oligosaccharides and
lipopolysaccharides in bacterial adherence, Trends
Microbiol. (1996) 4:408–409.
[19] Jacques M., Surface polysaccharides and iron-
uptake systems in Actinobacillus pleuropneumoniae,
Can. J. Vet. Res. (2004) 68:81–85.
[20] Kaplan J.B., Velliyagounder K., Ragunath C.,
Rohde H., Mack D., Knobloch J.K., Ramasubbu N.,
Genes involved in the synthesis and degradation of
matrix polysaccharide in Actinobacillus actinomyce-
temcomitans and Actinobacillus pleuropneumoniae
bioﬁlms, J. Bacteriol. (2004) 186:8213–8220.
[21] Kaplan J.B., Mulks M.H., Bioﬁlm formation is
prevalent among ﬁeld isolates of Actinobacillus pleu-
ropneumoniae, Vet. Microbiol. (2005) 108:89–94.
[22] Kerrigan J.E., Ragunath C., Kandra L., Gye ´mant
G., Liptak A., Janossy L., et al., Modeling and
biochemical analysis of the activity of antibioﬁlm
agent Dispersin B, Acta Biol. Hung. (2008) 59:
439–451.
[23] Koo H., Sheng J., Nguyen P.T., Marquis R.E.,
Co-operative inhibition by ﬂuoride and zinc of
glucosyltransferase production and polysaccharide
synthesis by mutans streptococci in suspension
cultures and bioﬁlms, FEMS Microbiol. Lett. (2006)
254:134–140.
[24] Li L., Zhou R., Li T., Kang M., Wan Y., Xu Z.,
Chen H., Enhanced bioﬁlm formation and reduced
virulence of Actinobacillus pleuropneumoniae luxS
mutant, Microb. Pathog. (2008) 45:192–200.
[25] Liu J., Tan C., Li J., Chen H., Xu P., He Q., et al.,
Characterization of ISApl1, an insertion element from
Actinobacillus pleuropneumoniae ﬁeld isolate in
China, Vet. Microbiol. (2008) 132:348–354.
[26] Liuzzi J.P., Lichten L.A., Rivera S., Blanchard
R.K., Aydemir T.B., Knutson M.D., et al., Interleukin-
6 regulateds the zinc transporter Zip 14 in liver and
contributes to the hypozincemia of the acute-phase
response, Proc. Natl. Acad. Sci. USA (2005)
102:6843–6848.
[27] Merritt J.H., Kadouri D.E., O’Toole G.A.,
Growing and analyzing static bioﬁlms, Curr. Protoc.
Microbiol. (2005) 1B.1.1–1B.1.17.
[28] Ramjeet M., Deslandes V., St Michael F., Cox
A.D., Kobisch M., Gottschalk M., Jacques M.,
Truncation of the lipopolysaccharide outer core affects
susceptibility to antimicrobial peptides and virulence
of Actinobacillus pleuropneumoniae serotype 1,
J. Biol. Chem. (2005) 280:39104–39114.
[29] Ramjeet M., Cox A.D., Hancock M.A., Mourez
M., Labrie J., Gottschalk M., Jacques M., Mutation in
the lipopolysaccharide outer core biosynthesis gene,
galU, affects LPS interaction with the RTX toxins
ApxI and ApxII and cytolytic activity of Actinobacil-
lus pleuropneumoniae serotype 1, Mol. Microbiol.
(2008) 70:221–235.
[30] Saeed A.I., Sharov V., White J., Li J., Liang W.,
Bhagabati N., et al., TM4: a free, open-source system
for microarray data management and analysis,
Biotechniques (2003) 34:374–378.
[31] Tegetmeyer H.E., Fricke K., Baltes N., An
isogenic Actinobacillus pleuropneumoniae AasP
mutant exhibits altered bioﬁlm formation but retain
virulence, Vet. Microbiol. (2009) 137:392–396.
[32] Tomich M., Planet P.J., Figurski D.H., The Tad
locus: postcards from the widespread colonization
island, Nat. Rev. Microbiol. (2007) 5:363–375.
[33] Tusher V.G., Tibshirani R., Chu G., Signiﬁcance
analysis of microarrays applied to the ionizing radia-
tion response, Proc. Natl. Acad. Sci. USA (2001)
98:5116–5121.
[34] Wagner T.K., Mulks M.H., A subset of
Actinobacillus pleuropneumoniae in vivo induced
promoters respond to branched-chain amino acids
limitation, FEMS Immunol. Med. Microbiol. (2006)
48:192–204.
[35] Wood T.K., Insights on Escherichia coli bioﬁlm
formation and inhibition from whole-transcriptome
proﬁling, Environ. Microbiol. (2009) 1:1–15.
Bioﬁlm formation in A. pleuropneumoniae Vet. Res. (2010) 41:03
(page number not for citation purpose) Page 17 of 17